Conditions : Arthropathy of Knee Joint; Osteoarthritis, Knee; Avascular Necrosis of Bone Intervention : Device: Triathlon (CR) Total Knee System Sponsor : Stryker Orthopaedics Active, not recruiting -...

Condition : Rheumatoid Arthritis Interventions : Drug: tocilizumab [RoActemra/Actemra]; Drug: Standard DMARDs (Disease Modifying Anti Rheumatic Drugs) Sponsor : Hoffmann-La Roche Not yet recruiting -...

Condition : Rheumatoid Arthritis Interventions : Drug: rituximab [MabThera/Rituxan]; Drug: methotrexate Sponsors : Hoffmann-La Roche; Hoffmann-La Roche Completed - verified September 2013

Condition : Rheumatoid Arthritis Interventions : Drug: rituximab [MabThera/Rituxan]; Drug: methotrexate Sponsor : Hoffmann-La Roche Completed - verified July 2011

The purpose of this study is demonstrate that subcutaneous abatacept is non-inferior (no worse than) to subcutaneous adalimumab in the treatment of subjects with rheumatoid arthritis who are biologic...

The purpose of this study is demonstrate that subcutaneous abatacept is non-inferior (no worse than) to subcutaneous adalimumab in the treatment of subjects with rheumatoid arthritis who are biologic...

Condition : Rheumatoid Arthritis Interventions : Biological: AIN457; Biological: AIN457; Biological: AIN457; Biological: AIN457; Biological: Placebo Sponsor : Novartis Pharmaceuticals Completed - veri...

Condition : Rheumatoid Arthritis Intervention : Drug: DMARDs or Biologics Sponsor : Pfizer Completed - verified August 2011

Condition : Rheumatoid Arthritis Interventions : Biological: AIN457; Biological: AIN457; Biological: AIN457; Biological: AIN457; Biological: Placebo Sponsor : Novartis Pharmaceuticals Completed - veri...

Condition : Rheumatoid Arthritis Intervention : Drug: DMARDs or Biologics Sponsor : Pfizer Completed - verified August 2011